NeuBase Therapeutics Inc (NBSE)
0.3905
-0.02
(-4.50%)
USD |
NASDAQ |
May 09, 16:00
0.378
-0.01
(-3.20%)
Pre-Market: 09:03
NeuBase Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2007 | -1.25K% |
| December 31, 2006 | |
| September 30, 2006 | |
| June 30, 2006 | |
| March 31, 2006 | 2.33% |
| December 31, 2005 | |
| September 30, 2005 | 4.34% |
| Date | Value |
|---|---|
| June 30, 2005 | -1.68% |
| March 31, 2005 | 3.75% |
| December 31, 2004 | -5.52% |
| September 30, 2004 | 3.61% |
| June 30, 2004 | 6.63% |
| March 31, 2004 | 5.10% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ampio Pharmaceuticals Inc | -- |
| Stoke Therapeutics Inc | -625.6% |
| ABVC BioPharma Inc | -143.7K% |
| MAIA Biotechnology Inc | -- |
| Aprea Therapeutics Inc | -- |